HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention? (Q64934974)

1 July 2019

title

HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention? (English)

1 reference

1 July 2019

1

Barton F Haynes

1 reference

1 July 2019

2

Nathan I Nicely

1 reference

1 July 2019

S Munir Alam

3

1 reference

1 July 2019

publication date

1 May 2010

1 reference

1 July 2019

Nature Structural & Molecular Biology

published in

1 reference

1 July 2019

volume

17

1 reference

1 July 2019

issue

5

1 reference

1 July 2019

page(s)

543-545

1 reference

1 July 2019

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Antibody neutralization and escape by HIV-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Fc receptor but not complement binding is important in antibody protection against HIV.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Virology. Moving forward in HIV vaccine development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Predominant autoantibody production by early human B cell precursors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Antigenic conservation and immunogenicity of the HIV coreceptor binding site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNSMB0510-543

31 March 2020

Identifiers

DOI

10.1038/NSMB0510-543

1 reference

1 July 2019

PMC publication ID

6071409

1 reference

1 July 2019

PubMed publication ID

20442740

1 reference

1 July 2019